No procedures, no twice-daily creams, no injections multiple times a week
Its active ingredient, tirzepatide, is a dual-agonist. It mimics not only GLP-1 but also another gut hormone called glucose-dependent insulinotropic polypeptide (GIP)
Kaplan-Meier survival curves compare the two treatment groups across primary and secondary outcomes, including (A) composite cardiovascular events, (B) systolic heart failure (SHF), (C) stroke, (D) all-cause mortality, and (E) acute myocardial infarction (MI)
Before worrying too much, it helps to know one important point
The benefits claimedreversal of aging, improved cognition, enhanced metabolismremain unproven in controlled human trials
It is being studied for that, but those results havent been published yet, he says